Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Perrigo ANDA approvals

This article was originally published in The Tan Sheet

Executive Summary

Private labeler is first to receive FDA approval for generic loperamide hydrochloride/simethicone chewable tablets (ANDA 76-029), equivalent to McNeil's Imodium Advanced, on Aug. 30. FDA nod comes about two months after Philadelphia federal judge deemed patent claims for Imodium Advanced invalid (1"The Tan Sheet" July 1, 2002, p. 3). Also on Aug. 30, Perrigo receives FDA approval of ANDA 76-195 for generic ranitidine tablets (Pfizer's Zantac 75)...

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts